A drug designed to keep pancreatic cancer and other tumorous tissues from recurring is being developed by scientists at the University of Oklahoma Health Sciences Center.
The medicine, probably in a pill or injectable form, would be given after patients are treated successfully using chemotherapy and radiation, said cancer researcher Dr. Courtney Houchen.
More than 400 Oklahomans are killed each year by pancreatic cancer, which is the fourth-leading cause of cancer fatalities in the United States, according to the National Cancer Institute.
Houchen said today at an Oklahoma City news conference that the drug has been effective in animal testing and cell cultures.
read more |
comments: 4